Translational profiling identifies sex-specific metabolic and epigenetic reprogramming of cortical

Shabana M Shaik1, Yajun Cao1, Joseph V Gogola1

  • 1Dept. of Neurobiology, The University of Chicago, Chicago, IL, USA.

Molecular Neurodegeneration
|December 16, 2023
PubMed
Abstract

Insights

Antibiotic treatment alters microglial function in a sex-specific manner, impacting Alzheimer's disease pathology. This study reveals sex-specific metabolic reprogramming in microglia, offering new therapeutic avenues for neurodegeneration.

Area of Science:

  • Neuroimmunology
  • Microbiology
  • Neurodegeneration
  • Alzheimer's Disease Research

Background:

  • Microglia, the brain's immune cells, change phenotypes during pathological processes to maintain homeostasis.
  • Previous studies showed antibiotic-induced gut microbiome changes in APPPS1-21 mice attenuated amyloidosis, particularly in males.
  • The molecular mechanisms driving microglial phenotypic shifts in response to gut microbiome alterations remain largely unknown.

Purpose of the Study:

  • To investigate the translational state of microglial/macrophage ribosomes during phenotypic transitions.
  • To explore sex-specific molecular events underlying microglial responses to gut microbiome perturbations in a mouse model of Alzheimer's disease.
  • To identify newly synthesized proteins in microglia/macrophages following antibiotic treatment.

Main Methods:

  • Generation of APPPS1-21-CD11br reporter mice.
  • Antibiotic (ABX) or vehicle treatment in male and female mice.
  • Immunoprecipitation of microglial/macrophage polysomes, followed by liquid chromatography-tandem mass spectrometry and label-free quantification.

Main Results:

  • ABX treatment decreased Aβ levels in male APPPS1-21 mice, with no significant effect in females.
  • Identified sex-specific changes in newly synthesized polypeptides related to mitochondrial function, calcium signaling, FcγR-mediated phagocytosis (males), and actin organization (females).
  • ABX treatment induced sex-specific epigenetic and metabolic reprogramming in microglia, promoting a neuroprotective phenotype in males and causing energy imbalance in females.

Conclusions:

  • This study provides the first translational profile of microglia/macrophages in an ABX-treated mouse model of Aβ amyloidosis.
  • ABX treatment reprograms microglial immunometabolism in a sex-specific manner, influencing immune responses and amyloid clearance.
  • Microglial plasticity in supporting neuro-energetic homeostasis is sex-dependent, highlighting potential for immunometabolism-based therapies in neurodegeneration.